From: Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
Etanercept cohort (N = 2725)
Discontinuations
1655 (60.7)
Remission
652 (23.9)
Inefficacy
594 (21.8)
Intolerance
192 (7.1)
Patient’s demand
504 (18.5)
Others
287 (10.5)